Yüklüyor......
Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients
The therapeutic scenario for elderly patients with advanced NSCLC has been limited to radiotherapy and chemotherapy. Recently, a novel therapeutic approach based on targeting the immune-checkpoints has showed noteworthy results in advanced NSCLC. PD1/PD-L1 pathway is co-opted by tumor cells through...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6539213/ https://ncbi.nlm.nih.gov/pubmed/31067796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20092258 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|